ipamorelin dosage for gh release Guide Benefits Protocols Uses CJC-1295 Ipamorelin Dosage Guide

Epithalon is identified by the FDA as a compound with potential immunogenicity concerns and is restricted from compounding use under current FDA rules

1999 Apr

European Journal of Endocrinology , 151(Suppl 1), S17S24

We are not a pharmacy, nor do we promote or provide any advice for human or animal consumption

Product Specifications CAS Numbers: Tesamorelin : 218949-48-5 Ipamorelin : 170851-70-4 Peptide Sequences: Tesamorelin: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 Ipamorelin: AibHis-D-2Nal-D-Phe-Lys Molecular Formulas: Tesamorelin: CHNOS Ipamorelin: CHNO Molecular Weights: Tesamorelin: 5136 g/mol Ipamorelin: 711.9 g/mol Synonyms: Tesamorelin: TH9507 Ipamorelin: NNC 26-0161 Category: Peptides Subcategory: Muscle Growth & Performance Peptides Purity: 99% (use lot-specific COA for the exact value) Packaging Format: 1 vial (Tesamorelin (10mg) + Ipamorelin (2mg)) Storage Conditions: Store at -20C, avoid light exposure Key Characteristics of 2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg) Complementary Peptides: A blend of GHRH-analog (Tesamorelin) and GHS-R agonist (Ipamorelin) peptides, frequently used in growth-hormone pathway studies

Moreover, data from pQCT scans tentatively indicated that the noted increase in cortical BMC might be related to an increase in the cross-sectional area of the bone